Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 12.892\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CCC(C(=O)Nc1ccc2c(c1)OCCO2)n1nnc2ccccc2c1=O
b) CC1(C)CC(=O)C(CC2=C(N)CC(C)(C)CC2=O)=C(N)C1
c) CCC(=O)Nc1ccc(NC(=O)CSc2nnc(-c3ccco3)n2C)cc1
Answer: a. CCC(C(=O)Nc1ccc2c(c1)OCCO2)n1nnc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C(=O)Nc1ccc2c(c1)OCCO2)n1nnc2ccccc2c1=O
CCC(C(=O)Nc1ccc2c(c1)OCCO2)n1nnc2ccccc2c1=O
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide